McCullagh Karl J A, Perlingeiro Rita C R
Department of Physiology, School of Medicine and Regenerative Medicine Institute, National University of Ireland Galway, Ireland.
Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Adv Drug Deliv Rev. 2015 Apr;84:198-207. doi: 10.1016/j.addr.2014.07.007. Epub 2014 Jul 15.
Skeletal muscle has a tremendous ability to regenerate, attributed to a well-defined population of muscle stem cells called satellite cells. However, this ability to regenerate diminishes with age and can also be dramatically affected by multiple types of muscle diseases, or injury. Extrinsic and/or intrinsic defects in the regulation of satellite cells are considered to be major determinants for the diminished regenerative capacity. Maintenance and replenishment of the satellite cell pool is one focus for muscle regenerative medicine, which will be discussed. There are other sources of progenitor cells with myogenic capacity, which may also support skeletal muscle repair. However, all of these myogenic cell populations have inherent difficulties and challenges in maintaining or coaxing their derivation for therapeutic purpose. This review will highlight recent reported attributes of these cells and new bioengineering approaches to creating a supply of myogenic stem cells or implants applicable for acute and/or chronic muscle disorders.
骨骼肌具有强大的再生能力,这归因于一群明确的肌肉干细胞,即卫星细胞。然而,这种再生能力会随着年龄的增长而减弱,并且还会受到多种类型的肌肉疾病或损伤的显著影响。卫星细胞调节中的外在和/或内在缺陷被认为是再生能力下降的主要决定因素。卫星细胞池的维持和补充是肌肉再生医学的一个重点,将对此进行讨论。还有其他具有成肌能力的祖细胞来源,它们也可能支持骨骼肌修复。然而,所有这些成肌细胞群体在维持或诱导其用于治疗目的的衍生方面都存在固有的困难和挑战。本综述将重点介绍这些细胞最近报道的特性以及新的生物工程方法,以创建适用于急性和/或慢性肌肉疾病的成肌干细胞供应或植入物。